Molecular targets of celastrol in cancer: Recent trends and advancements

D Kashyap, A Sharma, HS Tuli, K Sak… - Critical Reviews in …, 2018 - Elsevier
Despite the advancement in the well-equipped and sophisticated laboratories and facilities,
cancer remains to be a major cause of death worldwide. Consequently, further investigation …

Celastrol in cancer therapy: Recent developments, challenges and prospects

HY Lim, PS Ong, L Wang, A Goel, L Ding, ALA Wong… - Cancer Letters, 2021 - Elsevier
Cancer is one of the world's biggest healthcare burdens and despite the current
advancements made in treatment plans, the outcomes for oncology patients have yet to …

Celastrol as a pentacyclic triterpenoid with chemopreventive properties

P Yadav, V Jaswal, A Sharma, D Kashyap… - Pharmaceutical …, 2018 - Taylor & Francis
Celastrol is a highly investigated anticancer moiety. It is a pentacyclic triterpenoid, isolated
several decades ago with promising role in chemoprevention. Celastrol has been found to …

[HTML][HTML] Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies

C Wang, S Dai, X Zhao, Y Zhang, L Gong, K Fu… - Biomedicine & …, 2023 - Elsevier
Celastrol is a pentacyclic triterpenoid extracted from the traditional Chinese medicine
Tripterygium wilfordii Hook F., which has multiple pharmacological activities. In particular …

Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer

R Kannaiyan, MK Shanmugam, G Sethi - Cancer letters, 2011 - Elsevier
Identification of active constituents and their molecular targets from traditional medicine is an
enormous opportunity for modern pharmacology. Celastrol is one such compound that was …

Celastrol inhibits the growth of estrogen positive human breast cancer cells through modulation of estrogen receptor α

SY Jang, SW Jang, J Ko - Cancer letters, 2011 - Elsevier
Human estrogen receptor α (ERα) is a nuclear transcription factor that displays a major
therapeutic target for breast cancer. The transcriptional activity of ERα can be regulated by …

Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways

R Kannaiyan, KA Manu, L Chen, F Li, P Rajendran… - Apoptosis, 2011 - Springer
Celastrol, a plant triterpene has attracted great interest recently, especially for its potential
anti-inflammatory and anti-cancer activities. In the present report, we investigated the effect …

Celastrol: molecular targets of thunder god vine

A Salminen, M Lehtonen, T Paimela… - … and biophysical research …, 2010 - Elsevier
Celastrol, a quinone methide triterpene, is a pharmacologically active compound present in
Thunder God Vine root extracts used as a remedy of inflammatory and autoimmune …

[HTML][HTML] Molecular modulators of celastrol as the keystones for its diverse pharmacological activities

SW Ng, Y Chan, DK Chellappan… - Biomedicine & …, 2019 - Elsevier
In the recent years, much attention has been focused on identifying bioactive compounds
from medicinal plants that could be employed in therapeutics, which is attributed to their …

Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway

X Pang, Z Yi, J Zhang, B Lu, B Sung, W Qu… - Cancer research, 2010 - AACR
Understanding the molecular basis and target of traditional medicine is critical for drug
development. Celastrol, derived from Trypterygium wilfordii Hook F.(“Thunder of God Vine”) …